Extracorporeal shock wave lithotripsy (ESWL)
Extracorporeal shock wave lithotripsy (ESWL) is a medical procedure with 7 clinical trials. Currently 2 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
66.7%
2 of 3 finished
33.3%
1 ended early
2
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Early vs Delayed Extracorporeal Shock Wave Lithotripsy for Residual Stones After Percutaneous Nephrolithotomy
Efficacy of Different Modalities on Management of Renal Hard Stones
Comparison of Extracorporeal Shock Wave Lithotripsy Versus Retrograde Intrarenal Surgery in the Management of Renal Calculi
Flexible Ureteroscopy Versus Extracorporeal Shock Wave Lithotripsy
Management of Lower Pole Renal Hard Stones ≤2 cm
Clinical Trials (7)
Early vs Delayed Extracorporeal Shock Wave Lithotripsy for Residual Stones After Percutaneous Nephrolithotomy
Efficacy of Different Modalities on Management of Renal Hard Stones
Comparison of Extracorporeal Shock Wave Lithotripsy Versus Retrograde Intrarenal Surgery in the Management of Renal Calculi
Flexible Ureteroscopy Versus Extracorporeal Shock Wave Lithotripsy
Management of Lower Pole Renal Hard Stones ≤2 cm
A Prospective Observational Comparison of SMP and ESWL for the Treatment of Renal Stones ≥20 mm in Children (IAU-04)
A Trial Comparing Efficacy of HM3 Versus F2 Lithotripters for Stone Fragmentation
All 7 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 7